PUMA Celebrates its 75 th Anniversary and Rich History in Motorsport
Sports company PUMA kicked off the 2023 Formula 1 season with a special panel discussion to celebrate its legacy in Motorsport culture and discuss the importance of innovations in racewear production. It was the first of a series of events to mark PUMA’s 75th anniversary.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230303005219/en/
Panel Talk ahead of the 2023 Formula 1 season to celebrate PUMAs legacy in Motorsport culture. (Photo: Business Wire)
Founded in 1948, PUMA has been at the forefront of innovation throughout its history, pushing the boundaries of what is possible in performance, functionality, and design. PUMA's rich history in motorsport dates back to 2001, when JORDAN GRAND PRIX became the first Formula 1 racing team that PUMA supplied with both footwear and clothing. Since then, PUMA has collaborated with some of the biggest names in the sport, including Michael Schumacher and Lewis Hamilton, and produced the best product for the best teams like Mercedes-AMG Petronas F1, Scuderia Ferrari and Red Bull Racing.
The panel talk was held in Bahrain on March 1 and was moderated by Noemi de Miguel, a sports journalist and television presenter for DAZN together with experts — Thomas Josnik (Global Director Motorsport, PUMA), Mick Schumacher (Mercedes-AMG Petronas F1 Team Reserve driver), Gregor Huebner (Senior Manager Sports Marketing Motorsport, PUMA) and Maurizio Sicco (Consultant in Motorsport racewear, PUMA) — they explored PUMA’s milestones in motorsport, discussed racing products from different eras, and spoke about what motorsport represents today.
PUMA’s latest racing shoes, SPEEDCAT PRO, were designed based on functionality to support drivers in their high performance on track. Years of innovation and technology packed into a single shoe, the SPEEDCAT PRO uses state of the art materials for racing. The upper and lining are made of lightweight fabric for speed, comfort, and of course fire protection. To guarantee absolute control of the pedals, the SPEEDCAT PRO comes with a low-profile rubber outsole and an EVA wedge provides just the right amount of comfort while keeping the shoe light and nimble. The SPEEDCAT PRO was built in compliance with the latest FIA Homologation Regulations for Safety Equipment (FIA Standard 8856-2018) for the best protection in racing. The SPEEDCAT PRO also includes several design elements that pay homage to PUMA's racing heritage.
“PUMA is proud to celebrate its 75th anniversary this year and also our legacy in motorsport industry”, said Thomas Josnik Global Director Motorsport at PUMA. “Innovation, speed, and technology have always been at the heart of everything we do, and this event is a tribute to our commitment to pushing boundaries and driving change in the industry.”
The event was an exciting first step in this year of celebration of 75 years of PUMA's past, present, and future in motorsport, highlighting the brand's commitment to excellence and innovation in racewear.
Event recap (YouTube): HERE
Event pictures: HERE
PUMA 75 Lewis Hamilton Interview: HERE
PUMA
PUMA is one of the world’s leading sports brands, designing, developing, selling, and marketing footwear, apparel and accessories. For 75 years, PUMA has relentlessly pushed sport and culture forward by creating fast products for the world’s fastest athletes. PUMA offers performance and sport-inspired lifestyle products in categories such as Football, Running and Training, Basketball, Golf, and Motorsports. It collaborates with renowned designers and brands to bring sport influences into street culture and fashion. The PUMA Group owns the brands PUMA, Cobra Golf and stichd. The company distributes its products in more than 120 countries, employs about 18,300 people worldwide, and is headquartered in Herzogenaurach/Germany.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230303005219/en/
Contact information
PUMA
Gudrun Cämmerer
Teamhead Global Brand PR
gudrun.caemmerer@puma.com
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Nine-Time Emmy Winner, Eric Black, Named Edgio’s CTO/General Manager of Media27.3.2023 15:05:00 CEST | Press release
Edgio, Inc. (Nasdaq: EGIO), the platform of choice for speed, security and simplicity at the edge, today announced it has appointed Eric Black as CTO/General Manager, Media. Having been at the forefront of digital video and live event streaming with NBC Universal for more than twenty years, Black joins Edgio to lead the company’s growth in delivering the highest quality linear, live and on-demand video experiences, to every device worldwide. Prior to joining Edgio, Black led NBC Universal’s media technology strategy across a host of digital properties during pivotal moments in the evolution of live streaming. He managed the first-ever live stream of a Super Bowl in 2010, delivered six Olympic Games (including the Rio 2016 Olympic Games, the largest digital event in history at the time), 2018 FIFA World Cup, and Presidential debates. He also guided the team that launched NBC Universal’s Peacock in 2020. The systems built by Black have focused on both high concurrent traffic and scale, a
ASM Global Unveils Ambitious Plan Transforming Its Global Venue Portfolio Into World’s Most Sustainable Collection27.3.2023 15:00:00 CEST | Press release
ASM Global, through its corporate social responsibility platform, ASM Global Acts, and in partnership with Honeycomb Strategies, has announced a dramatic plan—the most aggressive in the live entertainment industry—to convert its portfolio into the most sustainable venues on Earth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230327005195/en/ Colorado Convention Center / Photo courtesy of ASM Global Beginning this year ASM Global will dedicate its full resources to achieving measurable results throughout its businesses using the most comprehensive tracking system in the venue space—intended to reflect that scale and create substantial collective impact on every continent it operates. The company working with its client partners already boasts the largest collection of certified green venues with over 40 and growing throughout the portfolio. In making the announcement, ASM Global President and CEO Ron Bension said, “Our curr
Merck Strengthens Oncology Franchise by Securing Exclusive Worldwide Rights to Anti PD-L1 Antibody BAVENCIO ® (avelumab)27.3.2023 14:00:00 CEST | Press release
Merck today announced it has strengthened its Oncology franchise by regaining exclusive worldwide rights to develop, manufacture, and commercialize anti-programmed death ligand-1 (PD-L1) antibody BAVENCIO® (avelumab) following the termination of their Alliance agreement with Pfizer. “On behalf of Merck, I’d like to thank Pfizer for their partnership and collaboration over the last nine years, and for the role they have played in the success of BAVENCIO,” said Belén Garijo, Chair of the Executive Board and CEO of Merck. “Our joint efforts have delivered meaningful therapeutic value to patients around the world who are living with cancer. This has been an incredible journey for us, and thanks to Pfizer’s partnership we are now very well positioned to continue to deliver this therapy to patients in need.” “Our alliance with Merck allowed us to combine our complementary strengths to develop and launch BAVENCIO to help meet the needs of people with cancer globally,” said Dr. Albert Bourla,
Ecoppia Expands its Global Presence with 4 New Projects in Spain and Chile with Matrix Renewables27.3.2023 14:00:00 CEST | Press release
Ecoppia, world’s leader in robotic cleaning solutions has announced an agreement to deploy its robotic solutions in 4 projects developed by Matrix Renewables, the TPG Rise-backed global renewable energy platform. This collaboration will mark Ecoppia’s first project in the Spanish region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230327005227/en/ Ecoppia H4 Autonomous Robotic Cleaning Solution (Photo: Business Wire) Ecoppia will deploy two robotic models at these PV sites – the Ecoppia H4 and the Ecoppia T4. Both robots are water-free and perform highly efficient cleaning while proven to be fully safe on the modules and structure. Ecoppia will also provide the operations and maintenance (O&M) to the robotics fleet for the projects’ lifetime. The expected total revenues from these projects during their lifespan is estimated at around $13M USD, of which $3.9M against the systems delivery and installation. This announcement
Vertex and CRISPR Therapeutics Announce Licensing Agreement to Accelerate Development of Vertex’s Hypoimmune Cell Therapies for the Treatment of Type 1 Diabetes27.3.2023 14:00:00 CEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) today announced that they have entered into a new non-exclusive licensing agreement for the use of CRISPR Therapeutics’ gene editing technology, known as CRISPR/Cas9, to accelerate the development of Vertex’s hypoimmune cell therapies for type 1 diabetes (T1D). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230324005339/en/ “We have multiple programs in our T1D portfolio including VX-880 and VX-264, which are in the clinic, as well as our hypoimmune program, in preclinical development,” said Bastiano Sanna, Ph.D., Executive Vice President and Chief of Cell and Genetic Therapies at Vertex. “Having successfully demonstrated clinical proof of concept in T1D in our VX-880 program, we are excited to deepen our relationship with CRISPR Therapeutics with this agreement, which will allow us to further accelerate our goal of generating fully dif